126results about How to "Inhibition of lesions" patented technology

Excitation light for normal light observation with wavelengths in the visible spectrum, which is output from a lamp, and excitation light with wavelengths in the infrared spectrum for exciting a fluorescent substance characteristic of being accumulated readily in a lesion are irradiated simultaneously to a living tissue, to which the fluorescent substance has been administered, through an endoscope. Fluorescence components are separated from light stemming from the living tissue by means of a separator such as a dichroic mirror, introduced to a first imaging device, and then imaged. Light components with wavelengths in the visible spectrum are introduced to a second imaging device and then imaged. Signals representing the images are subjected to signal processing, whereby a video signal is produced. For better diagnosis, two images are displayed while, for example, one of the images is superimposed on the other.

The invention relates to a device that can be used to monitor the penetration of a penetration member into anatomical structures and, in particular, bone structures of a living body, the structures having at least two different electrical impedance areas. The device is characterized in that it comprises: at least one impedance meter which can be connected to at least two electrodes, at least one of the electrodes being located at a distal end of the penetration member; and at least one alert device which can produce an alert signal if the impedance meter detects an impedance variation. The invention also relates to a penetration member for the device and to an electronic board for the device.

Methods and systems are disclosed for phototreatment in which replaceable containers comprising one or more adjuvant (consumable or re-useable) substances are employed. The adjuvant substance can be, for example, a topical substance or a coolant. Systems are disclosed for using a topical substance to detect contact of a phototreatment device with a tissue, detect speed of a phototreatment device over the tissue, detect regions of tissue that have been treated by a phototreatment device and / or to provide other benefits to the tissue such as improved skin tone and texture, tanning, etc. Safety systems are also disclosed that ensure that a proper consumable substance and / or container is connected to a phototreatment device and / or directed to a proper target. Additionally, cooling systems and methods that utilize phase change materials for extracting heat from a light generating device are disclosed.

A method for treating or preventing cardiovascular pathologies by administering a compound of the formula (I):wherein Z is C═O or a covalent bond; Y is H or O(C1–C4)alkyl, R1 and R2 are individually (C1–C4)alkyl or together with N are a saturated heterocyclic group, R3 is ethyl or chloroethyl, R4 is H or together with R3 is —CH2—CH2— or —S—, R5 is I, O(C1–C4)alkyl or H, and R6 is I, O(C1–C4)alkyl or H with the proviso that when R4, R5, and R6 are H, R3 is not ethyl; or a pharmaceutically acceptable salt thereof, effective to activate or stimulate production of TGF-beta to treat and / or prevent conditions such as atherosclerosis, thrombosis, myocardial infarction, and stroke is provided. Useful compounds include idoxifene and salts thereof. Further provided is a method for identifying a compound that is a TGF-beta activator or production stimulator is provided. Another embodiment of the invention is an assay or kit to determine TGF-beta in vitro. Also provided is a therapeutic method comprising inhibiting smooth muscle cell proliferation associated with procedural vascular trauma employing the administration of tamoxifen or structural analogs thereof, including compounds of formula (I).

Dosimeters 140 are housed in dosimeter housing pockets 130 of a dosimeter fitting wear including: wear main bodies 120, 150 which cover measuring positions on at least subject bodies 100, 102, and 110, and can be detachably fitted on the subject bodies, and the dosimeter housing pockets 130 provided at positions that come to the measuring positions when the wear main bodies are fitted on the subject bodies, and then the wear main bodies are fitted on the subject bodies. Thereby, a number of dosimeters can be easily fitted on or detached from the surfaces of subject bodies without hindering medical activities, and set positions of the dosimeters can be easily reproduced.

In an image-processing method for the detection of radiological signs in series of 3D data, an algorithm is used to detect radiological signs in a digital volume according to their contrasts. This algorithm is applied to reconstructed slices or directly to the series of projections. This algorithm is made by means of linear differential filters for signal analysis. It is used to color or enhance the intensity of the detected radiological signals according to the degree of malignancy.

Dosimeters 140 are housed in dosimeter housing pockets 130 of a dosimeter fitting wear including: wear main bodies 120, 150 which cover measuring positions on at least subject bodies 100, 102, and 110, and can be detachably fitted on the subject bodies, and the dosimeter housing pockets 130 provided at positions that come to the measuring positions when the wear main bodies are fitted on the subject bodies, and then the wear main bodies are fitted on the subject bodies. Thereby, a number of dosimeters can be easily fitted on or detached from the surfaces of subject bodies without hindering medical activities, and set positions of the dosimeters can be easily reproduced.

The invention relates to the field of fish feed, in particular to special feed formulation for giant salamanders. The special feed formulation is composed of, by weight, 20-30 parts of sorghum, 45-60 parts of meat meal, 1-3 parts of pollen, 2-3 parts of Radix Astragali, 0.05-0.1 part of Ganoderma, 4-6 parts of Rhizoma Dioscoreae, 10-15 parts of sweet potatoes, 5-10 parts of peeled soybean meal, 15-20 parts of egg yolk powder, 3-4 parts of complex vitamins, 1-2 parts of mineral substances, 0.03-0.04 part of aspartic acid, 0.04-0.06 part of glutamic acid, 0.02-0.03 part of lysine, 0.02-0.03 part of leucine, 0.01-0.02 part of tryptophan and 0.35-0.4 part of salt. The special feed formulation for the giant salamanders has the advantages that by scientific matching according to actual nutritional requirements of the giant salamanders, autoimmunity of the giant salamanders can be improved, morbidity of the giant salamanders is reduced, and growth cycle of the giant salamanders can be shortened.

The present invention is generally directed toward therapeutic compositions for treating infections caused by Herpes Simplex Virus (“HSV”). The therapeutic compositions meet a long felt need in the art of providing a treatment for lesions that result from HSV that drastically reduce the duration of a cold sore when vesicles have already appeared and a treatment that will prevent the outbreak of a lesion and formation of vesicles when applied in the prodormal stage. The therapeutic compound comprises a mixture of Acyclovir (“ACV”), Penciclovir (“PCV”), and 2-Deoxy-D-Glucose (“2-DDG”). The therapeutic compositions of the present invention include multiple formulations of the three active ingredients and may also include inactive ingredients.